Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624 [Phase 3]
Phase 3 trial evaluating short versus long-term androgen deprivation therapy in combination with salvage radiotherapy for prostate cancer; c…
-
CLINICAL_TRIALS trial_result · 2023-11-14Clinical Trial Update: Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy [Phase 1]
Phase 1 results from a study evaluating SBRT for locally recurrent prostate cancer after prior radiotherapy.
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: 68Ga-PSMA-11 PET in Patients With Prostate Cancer [Phase 3]
Phase 3 clinical trial update on 68Ga-PSMA-11 PET in prostate cancer, with completed status and results posted.
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local Surgery [Phase 3]
Phase 3 trial update for RADICALS evaluating radiotherapy and androgen deprivation after local surgery in prostate cancer.
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: Neoadjuvant Androgen Deprivation, Darolutamide, and Ipatasertib in Men With Localized, High Risk Prostate Cancer [Phase 1, Phase 2]
Clinical trial update for neoadjuvant androgen deprivation with darolutamide and ipatasertib in localized high-risk prostate cancer; study t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-11-03Clinical Trial Update: Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence [Phase 2]
Phase 2 clinical trial evaluating Gallium-68 PSMA-11 PET imaging in patients with biochemical recurrence of prostate cancer; results posted …
-
CLINICAL_TRIALS trial_result · 2023-11-02Clinical Trial Update: BAY88-8223, Dose Finding Study in Patients With HRPC [Phase 2]
Phase 2 dose-finding trial of BAY88-8223 in hormone-refractory prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-11-02Clinical Trial Update: A Phase 1 Study To Evaluate Escalating Doses Of A Vaccine-Based Immunotherapy Regimen For Prostate Cancer (PrCa VBIR) [Phase 1]
Phase 1 study of escalating doses of a vaccine-based immunotherapy regimen for prostate cancer (PrCa VBIR) was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2023-10-31Clinical Trial Update: First in Man Clinical Study to Evaluate Safety and Tolerability of an Oncolytic Adenovirus in Prostate Cancer Patients. [Phase 1, Phase 2]
First-in-man clinical study to evaluate safety and tolerability of an oncolytic adenovirus in prostate cancer patients (Phase 1/2).
-
CLINICAL_TRIALS trial_result · 2023-10-31Clinical Trial Update: Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating docetaxel with or without thalidomide in metastatic prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-10-30Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer. [Phase 1]
Phase 1 trial evaluating safety, pharmacokinetics, and efficacy of Ipatasertib with Rucaparib in advanced breast, ovarian, and prostate canc…
-
CLINICAL_TRIALS trial_result · 2023-10-26Clinical Trial Update: Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer [Phase 2]
A Phase 2 trial evaluating antiandrogen therapy (abiraterone acetate) with or without neutron radiation therapy in castration-sensitive/pros…
-
CLINICAL_TRIALS trial_result · 2023-10-25Clinical Trial Update: Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery [Phase 4]
Phase 4 clinical trial evaluating perioperative intravenous lidocaine infusion in robotic-assisted urologic surgery has been terminated with…
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: Study of 18F-Florastamin PET/CT Imaging in Patients With at Least Intermediate Risk Prostate Cancer [Phase 3]
Clinical trial update for a Phase 3 study evaluating 18F-Florastamin PET/CT imaging in patients with at least intermediate risk prostate can…
-
CLINICAL_TRIALS trial_result · 2023-10-18Clinical Trial Update: PSCA-CAR T Cells in Treating Patients With PSCA+ Metastatic Castration Resistant Prostate Cancer [Phase 1]
Phase 1 clinical trial evaluating PSCA-CAR T cells in PSCA-positive metastatic castration-resistant prostate cancer; study is active not rec…
-
CLINICAL_TRIALS trial_result · 2023-10-17Clinical Trial Update: Brachytherapy for Recurrent Prostate Cancer [Phase 2]
Phase 2 clinical trial update on brachytherapy for recurrent prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-10-12Clinical Trial Update: Multi-parametric Magnetic Resonance Imaging for Prostate Cancer Patients [NA]
Clinical trial update for multi-parametric MRI in prostate cancer was terminated; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-10-06Clinical Trial Update: GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer [Phase 2]
Phase 2 clinical trial update for GTx-758 in men with castration-resistant prostate cancer; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2023-10-06Clinical Trial Update: Tracer-Guided Surgery for Recurrent Prostate Cancer [Phase 2]
Phase 2 clinical trial update for tracer-guided surgery in recurrent prostate cancer.
-
CLINICAL_TRIALS trial_result · 2023-10-05Clinical Trial Update: Multivalent Conjugate Vaccine Trial for Patients With Biochem. Relapsed Prostate Cancer [Phase 2]
Phase 2 clinical trial update for a multivalent conjugate vaccine in biochemically relapsed prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-10-04Clinical Trial Update: A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer [Phase 3]
Phase 3 trial evaluating niraparib in combination with abiraterone acetate and prednisone versus abiraterone acetate and prednisone for meta…
-
CLINICAL_TRIALS trial_result · 2023-10-03Clinical Trial Update: COMbination of Bipolar Androgen Therapy and Nivolumab [Phase 2]
Phase 2 trial evaluating the combination of Bipolar Androgen Therapy with Nivolumab in prostate cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-09-26Clinical Trial Update: Enzalutamide With or Without Vaccine Therapy for Advanced Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating enzalutamide with or without vaccine therapy in advanced prostate cancer has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2023-09-26Clinical Trial Update: Copper-64 SAR Bombesin in PSMA Negative Prostate Cancer (BOP) [Phase 2]
Phase 2 clinical trial of Copper-64 SAR Bombesin in PSMA-negative prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-09-22Clinical Trial Update: A Trial of Androgen Deprivation, Docetaxel, and Enzalutamide for Metastatic Prostate Cancer [Phase 2]
Phase 2 clinical trial update evaluating androgen deprivation combined with docetaxel and enzalutamide for metastatic prostate cancer; resul…